Catalyst Wire Dossier Catalyst Wire Dossier

Nitric Oxide Reduction

· Arginox Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nitric Oxide Reduction, covering 2006-08-04 to 2006-08-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack [Phase 3]

See pricing